Does hyperoxia affect glucose regulation and transport in the newborn?  by Bandali, Karim S. et al.
Does hyperoxia affect glucose regulation and transport in
the newborn?
Karim S. Bandali, BSc, MSca
Michael P. Belanger, ALATb
Carin Wittnich, MSc, DVMa,b,c
Objective: Hyperglycemia has been found to occur in children placed on cardio-
pulmonary bypass. Our laboratory demonstrated that hyperoxia plays a role in this
hyperglycemic response and also occurs in the absence of cardiopulmonary bypass.
The purpose of this study was to elucidate potential mechanisms underlying the
hyperoxic-induced hyperglycemia by examining glucagon, insulin, and epinephrine,
which are important in glucose regulation and skeletal and cardiac glucose trans-
porters (GLUT1 and GLUT4), which facilitate glucose entry.
Methods: Three-day-old piglets were anesthetized, intubated, and ventilated to
normoxia. Animals were then randomly allocated to either 5 hours of normoxia (n
 4) or hyperoxia (n  6). Measurements of oxygen, blood glucose, plasma
glucagon, insulin, and epinephrine levels were made. Total GLUT1 and GLUT4
content in cardiac and skeletal muscle was measured using Western blotting anal-
ysis.
Results: A sustained hyperglycemic response (P  .001) was seen throughout the
5-hour ventilatory period. A significant twofold elevation in glucagon levels (P 
.001) and a threefold elevation (P .003) in plasma insulin levels occurred, despite
no significant changes in plasma epinephrine. Total GLUT1 and GLUT4 content
were significantly reduced in skeletal muscle by 66% and 59%, respectively, while
no significant changes occurred in cardiac muscle.
Conclusion: This study demonstrates that significant elevations in glucagon and
insulin and reductions in total skeletal muscle GLUT1 and GLUT4 content all
contribute to hyperoxia-induced hyperglycemia seen in newborns. To optimize
postoperative recovery of newborns, consideration should be given to the levels of
oxygen used to avoid the potential development of insulin resistance and subsequent
decrease in glucose entry.
Hyperglycemia has been found to occur in children suffering fromcongenital heart disease who are placed on cardiopulmonarybypass (CPB) for primary cardiac repair.1-3 Persistent hypergly-cemia in children has been shown to cause osmotic diuresis,dehydration, glycosylation of proteins, and an increased incidencein cerebral hemorrhage.4,5 Previous studies, mainly performed in
adults, have identified several different factors associated with the development of
this hyperglycemic response including hypothermia, hypokalemia, and hypocalce-
mia.6-8 However, none of these factors have been consistently implicated.6,9-11
Infants and children suffering from congenital heart disease are often exposed to
hyperoxia for varying duration during CPB or extracorporeal membrane oxygen-
ation.12-15 Under these conditions, systemic hyperoxia can reach an arterial partial
pressure of oxygen (PaO2) range of 250 to 500 mm Hg, which can last for 2 to 5
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hours during a cardiac operation or several days during
extracorporeal membrane oxygenation.12,15
We examined a cohort of children undergoing routine
CPB for primary repair for congenital defects at the Hospi-
tal for Sick Children (Toronto, Canada) and found that
despite normal preoperative blood glucose levels, during
surgery they demonstrated a significant and strong positive
correlation between their absolute oxygen and blood glu-
cose levels.3 This identified that hyperoxia is indeed an
important contributor to the hyperglycemic response seen in
children who are placed on CPB. This clinical finding was
further substantiated by our laboratory using a newborn pig
model, which documented that high oxygen levels (hyper-
oxia) trigger the same hyperglycemic response whether a
CPB model was used or just simply a ventilatory model.3
This work suggests that hyperoxia may not only play a
crucial role in the hyperglycemic response seen during
neonatal cardiopulmonary bypass but also that its effect on
glucose homeostasis should be considered whenever chil-
dren are exposed to hyperoxia.
The goal of this study was to begin to elucidate the
mechanisms underlying hyperoxia-induced hyperglycemia
found in newborns. Due to the rapid nature of this systemic
hyperglycemia, the potential role of hormones important in
glucose homeostasis including insulin, glucagon, and epi-
nephrine were examined. In addition, as muscle comprises a
large portion of body mass (primarily skeletal muscle) and
uses glucose as one of its metabolic substrates, any alter-
ations to skeletal and cardiac glucose entry could also have
a significant impact on systemic glycemia. Glucose entry in
skeletal and cardiac muscle cells is facilitated by glucose
transporters: GLUT1 (insulin-independent) and GLUT4 (in-
sulin-dependent).16 Work examining the effect of hyperoxia
on L6 muscle cell cultures has shown significant decreases
in GLUT1 content while reporting no significant changes in
GLUT4. In contrast to adult cardiac and skeletal muscle, the
fetus has a very high GLUT1 content while the GLUT4
content is reported to be very low.17 Because the neonate
represents a transition from fetal to adult, both GLUT1 and
GLUT4 may be particularly important in facilitating glu-
cose entry in both newborn cardiac and skeletal muscle. The
effect of hyperoxia on insulin, glucagon, and epinephrine
levels as well as glucose transporter content in newborn
heart and skeletal muscle is unknown and was the focus of
this study. The ventilatory model used in this study provides
an opportunity to begin investigating the underlying mech-
anisms of hyperoxia-mediated hyperglycemia in the ab-
sence of any confounding variables that may be introduced
during CPB.
Materials and Methods
Neonatal Yorkshire pigs were chosen as the animal model in
which to study the effects of hyperoxia because the cardiac and
pulmonary systems of newborn humans and pigs have many
structural and functional similarities.18 Yorkshire pigs (3 days old,
1.5 to 2.5 kg) were used in this study and were provided with
sow’s milk replacer (Grober Animal Nutrition, Cambridge, On-
tario, Canada) until the time of surgery. Animals were anesthetized
with an intraperitoneal injection of sodium pentobarbital (65 mg/
kg) (MTC Pharmaceuticals, Cambridge, Ontario, Canada), intu-
bated, and mechanically ventilated to normal blood gases (PaO2 
88  6 mm Hg, PaCO2  38  5 mm Hg) with medical air.
Anesthesia was maintained with diluted (1:5) sodium pentobarbital
via a catheter in the right carotid artery as needed to maintain an
appropriate plane of anesthesia. Normothermia (37.9  0.2°C)
was maintained in each piglet. A catheter was inserted into the
right carotid artery and advanced to the aortic arch to monitor
arterial blood pressure via a pressure transducer (COBE, Lake-
wood, Colo), which was connected to a physiologic recorder
(BIOPAC Systems Inc, Goleta, Calif). This catheter was also used
for supplemental anesthesia administration, sampling of blood
gases, and glucose measurements.
Arterial blood gases (PaO2 and PaCO2) and acid-base status (pH
and bicarbonate [HCO3]) were monitored at regular intervals
using an ABL30 Acid-Base Analyzer (Radiometer, Copenhagen,
Denmark), and appropriate ventilatory adjustments ensured that
PaO2 and PaCO2 remained at the desired levels.
Experimental Protocol
Animals were then randomly allocated to 5 hours of normoxia
control (84  6 mm Hg; n  4) or hyperoxia (434  39 mm Hg;
n  6). Measurements of PaO2 were made at hourly intervals.
Blood glucose as well as plasma samples for hormone analysis
were taken at normoxia baseline, near the halfway point of the
ventilatory protocol and at the end of the 5-hour ventilatory pro-
tocol.
Blood glucose measurements were made using the Accu-Chek
Advantage Blood Glucose Monitoring System (Boehringer Mann-
heim, Laval, Quebec, Canada). Plasma insulin measurements were
made using a porcine insulin enzyme-linked immunosorbent assay
(ALPCO Diagnostics, Windham, NH), and plasma glucagon mea-
surements19 as well as plasma epinephrine levels were made by
radioimmunoassay (ALPCO Diagnostics).
Mixed fiber-type skeletal muscle freeze-clamp biopsy speci-
mens were taken from the hind limb of each piglet at normoxia
baseline as well as at the end of the ventilatory protocol, and left
ventricular myocardial biopsy specimens were taken only at the
end of the ventilatory period for subsequent Western blotting
analysis of glucose transporter (GLUT1 and GLUT4).
Total Membrane Isolation
Skeletal muscle as well as cardiac muscle (left ventricle [LV])
biopsy specimens were homogenized and centrifuged at 1200g and
9000g. Supernatants were then centrifuged at 190,000g and the
resulting pellet containing total cell membranes was resuspended
in a small volume of homogenizing buffer. Protein concentration
was assayed by Bradford method using a BCA protein assay kit
(Pierce, Rockford, Ill).
Western Blotting Analysis
Homogenate samples (30 g of protein) were solubilized in an
equal volume of Laemmli sample buffer. Proteins were subjected
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to sodium dodecylsulfate polyacrylamide gel electrophoresis and a
Western blotting protocol adapted from Bashan and colleagues.20
GLUT protein signals were detected using enhanced chemilumi-
nescence (Amersham Pharmacia Biotech Inc, Piscataway, NJ) and
quantified using autoradiography and densitometry.
All experimental procedures and protocols used in this inves-
tigation were reviewed and approved by the University of Toronto
Animal Care and Use Committee and are in accordance with the
National Institute of Health Guide for the Care and Use of Labo-
ratory Animals (NIH publication no. 85-23, revised 1985) and
Canadian Council on Animal Care guidelines.
Statistical Analysis
Repeated measures ANOVA with Duncan multiple range test post
hoc was used to identify blood glucose differences between nor-
moxic and hyperoxic groups and across time in the ventilatory
model. Paired t tests were used to determine significant differences
between baseline and end ventilatory hormone levels in the nor-
moxic group as well as skeletal muscle GLUT1 and GLUT4
content. Student t tests were used to determine differences between
LV GLUT1 and GLUT4 content between normoxic and hyperoxic
piglets. One-way ANOVA with a Bonferroni post hoc test was
used to analyze difference in hormone levels in the hyperoxic
group at baseline and at 2.5- and 5-hour marks, respectively. All
data are expressed as mean  SEM.
Results
Development of Hyperglycemia
This study first confirmed that piglets exposed to hyperoxia
had a significant hyperglycemic response compared with
piglets exposed to normoxia. This response was well estab-
lished by the midpoint of the hyperoxic ventilation and did
not increase but was sustained over the course of the re-
mainder of the ventilatory period (Figure 1).
Hormones: Plasma Glucagon, Insulin, and
Epinephrine
No significant changes in hormone levels were observed in
piglets that underwent 5 hours of normoxic ventilation
(Table 1). In contrast, piglets that underwent 5 hours of
hyperoxia showed a significant and progressive increase in
plasma glucagon (Figure 2) and plasma insulin levels (Fig-
ure 3) from baseline. No significant changes were noted in
plasma epinephrine levels after 2.5 or 5 hours of hyperoxia
(Figure 4). This suggests that both glucagon and insulin play
an important role in the development of hyperoxia-induced
hyperglycemia.
Glucose Transporters (GLUT1 and GLUT4)
No significant differences in LV total GLUT1 or GLUT4
content were noted in between normoxic and hyperoxic
piglets (Figure 5). In contrast, exposure to 5 hours of hy-
peroxia resulted in a significant 66% reduction in skeletal
Figure 1. Blood glucose levels taken at baseline (normoxia), near
the midpoint, and at the end of 5 hours of hyperoxia in newborn
pigs. Broken lines represent the range of blood glucose levels
measured in normoxic newborn pigs at the same time intervals.
*P < .0001 versus baseline.





Insulin (g/mL) 0.096 0.002 0.103 0.007
Glucagon (pg/mL) 182.30 32.54 221.28 23.33
Epinephrine (ng/mL) 9.58 0.62 9.53 1.14
Figure 2. Plasma glucagon levels taken at baseline (normoxia),
near the midpoint, and at the end of 5 hours of hyperoxia in
newborn pigs. *P  .007 versus baseline; †P  .001 versus
baseline and versus 2.5 hours.
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muscle total GLUT1 content and a 59% reduction in total
GLUT4 content compared with measurements made at
baseline normoxia (Figure 6).
Discussion
Children undergoing surgical repair for congenital heart
disease are often placed on CPB during cardiac operations.
Hyperoxia is a common occurrence in during CPB and
historically the rationale for its use was to overcome the
hypothermia-induced shift of the oxygen-hemoglobin dis-
sociation curve and thus ensure adequate oxygen delivery.21
The potentially detrimental effects of hyperoxia are rarely
considered. Work in our laboratory has documented that
hyperoxia triggers a hyperglycemic response in both venti-
latory and CPB settings. Persistent hyperglycemia in chil-
dren has been shown to cause osmotic diuresis, dehydration,
glycosylation of proteins, and an increased incidence in
cerebral hemorrhage.4,5
It is speculated from the hormone profiles elucidated in
this study that the hyperoxia-mediated increase in plasma
glucose was driven by significantly elevated levels of glu-
cagon. However, the reason for this significant increase in
plasma glucagon levels remains unclear as epinephrine, a
known regulator of glucagon release, wasn’t shown to sig-
nificantly change with 5 hours of hyperoxia. However, the
direct action of oxygen on the pancreas may be a possible
consideration since work by Kobasyashi and colleagues22
shows an abundant expression of oxygen-regulated protein
(ORP150) in the adult mouse pancreas. They showed that
Figure 3. Plasma insulin levels taken at baseline (normoxia),
near the midpoint, and at the end of 5 hours of hyperoxia in
newborn pigs. *P .01 versus 5 hours; †P .001 versus baseline.
Figure 4. Plasma epinephrine levels taken at baseline (normoxia)
near the midpoint and at the end of 5 hours of hyperoxia in
newborn pigs.
Figure 5. Total LV GLUT1 and GLUT4 content in newborn pigs
after 5 hours of normoxia and hyperoxia. Representative Western
blots are shown with each graph.
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when ORP150 expression was increased, glucagon as well
as insulin secretion also increased. If hyperoxia causes
increases in ORP150 expression then this could account, at
least in part, for the increases seen in our study. This is
currently unknown, as is whether ORP150 is even present in
the newborn.
Along with the marked increase in plasma glucagon,
significant increases in plasma insulin levels were also
observed, which most likely are a result of the elevated
plasma glucose levels. The persistence of hyperglycemia in
the face of this marked increase in insulin therefore would
imply the potential development of insulin resistance with
exposure to hyperoxia. Evidence in the literature does sug-
gest that the development of insulin resistance can be linked
with hyperoxia as well as hyperglycemia through the pro-
duction of oxygen free radicals. Both of these have been
shown to increase the production of oxygen free radicals,
which can overwhelm the cell’s antioxidant systems.23-25
Oxygen free radicals have been shown in both adipocyte
and muscle cell cultures to be associated with the develop-
ment of insulin resistance through the inhibition of insulin
signaling responsible for the translocation of GLUT4 from
intracellular vesicles to the plasma membrane.26-28 Some
recent preliminary work appears to show that hyperoxia
exposure does significantly increase oxygen free radical
production, since malondialdehyde levels, which serve as a
measure of lipid peroxidation secondary to oxygen free
radical–mediated membrane injury in cardiac tissue, went
up. Therefore, both hyperoxia and hyperglycemia may con-
tribute to the development of insulin resistance seen in this
model through the production of oxygen free radicals.
In addition to the significant alterations in plasma gluca-
gon and insulin levels, this study also documents significant
reductions in total content of skeletal muscle GLUT1 and
GLUT4. This is an important finding as skeletal muscle is
the main tissue involved in the insulin-induced stimulation
of glucose uptake and therefore the reduction of its total
glucose transporter content represents a major contributor to
the hyperoxia-induced hyperglycemia response. The signif-
icant reductions in skeletal muscle GLUT1 and GLUT4
may involve both hyperoxia and hyperglycemia docu-
mented in this study. However, unlike the mechanism pro-
posed for the development of insulin resistance where both
parameters are linked to oxygen free radical production,
these 2 parameters may regulate glucose transporters inde-
pendently in an isoform-specific manner. The findings in
this current study are consistent, in part, with L6 muscle cell
culture work performed in which 48 hours of hyperoxia led
to significant reductions in total GLUT1 content. Therefore,
the primary effect of hyperoxia on total glucose transporters
content seems to involve the down-regulation of GLUT1. It
is unclear whether this regulatory decrease in total GLUT1
content is a result of increased GLUT1 protein degradation
or alternatively a result of a decrease in GLUT1 gene
transcription.
With respect to GLUT4, this current study documents a
significant reduction in total GLUT4 content in skeletal
muscle, which is inconsistent with muscle cell culture work
that showed no significant change in total GLUT4 content.
This discrepancy may be explained in part by the utilization
of a whole animal model in this study, which allowed for the
presence of other variables affected by hyperoxia such as
elevations in glucose and insulin. GLUT4 is known to be
regulated by both of these variables. Specifically, GLUT4
has been shown to be internalized, thereby decreasing
plasma membrane content in response to hyperglycemia in
skeletal muscle,29 while work performed in 3T3-L1 mouse
adipocytes has shown that in the presence of hyperinsulin-
emia, there is a down-regulation of GLUT4 mRNA as a
result of both rapid repression of transcription of the
Figure 6. Total skeletal muscle GLUT1 and GLUT4 content in
newborn pigs after 5 hours of normoxia and hyperoxia. Repre-
sentative Western blots are shown with each graph. †P < .001
versus normoxia.
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GLUT4 gene and an increased rate of turnover of the
GLUT4 message.30 If similar mechanisms are at work in the
newborn model used in this study where hyperinsulinemia
has been clearly documented to accompany the hypergly-
cemic response, then this may provide a potential explana-
tion for the significant reduction in total GLUT4 content.
Therefore, the regulation of GLUT1 and GLUT4 expression
in skeletal muscle may involve both oxygen and metabo-
lism.
In contrast to the significant reductions in total glucose
transporter content seen in skeletal muscle, myocardial
GLUT1 and GLUT4 showed a smaller reduction in total
content that did not reach statistical significance. Even
though reductions in total glucose transporter content were
surprisingly not observed in the heart, the potential devel-
opment of insulin resistance seen in this study may still limit
glucose entry and compromise newborn heart function. Be-
cause the contribution of skeletal muscle to insulin-induced
stimulation of glucose uptake is greater compared with the
newborn heart, the systemic hyperglycemia seen in this
study can still be attributed in part to the reductions in total
GLUT1 and GLUT4 content in skeletal muscle.
In conclusion, this study demonstrated that significant
elevations in glucagon and insulin and reductions in total
skeletal muscle GLUT1 and GLUT4 content all contribute
to hyperoxia-induced hyperglycemia seen in newborns. As
a result of these changes, these findings highlight the sys-
temic nature of the effects of hyperoxia, which may have
potentially important implications concerning the overall
postoperative recovery of newborns placed on CPB for
primary cardiac repair. Therefore, to optimize postoperative
recovery of newborns, consideration may need to be given
to adjustments in levels of oxygen used clinically to avoid
the potential development of insulin resistance and subse-
quent decrease in glucose entry.
We wish to thank Dr P. Brubaker for her assistance with the
glucagon radioimmunoassay.
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